Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma.

Author List

Amin A, Lawson DH, Salama AK, Koon HB, Guthrie T, Thomas SS, O'Day SJ, Shaheen MF, Zhang B, Francis S, Hodi FS

Publication

Publication ID (Profile URL)

https://researcherprofiles.org/profile/679815296

Publication Year

2016

PubMed ID

27532019